Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1966 Jul 1;124(1):81-97.
doi: 10.1084/jem.124.1.81.

Infectious virus-antibody complex in the blood of chronically infected mice

Infectious virus-antibody complex in the blood of chronically infected mice

A L Notkins et al. J Exp Med. .

Abstract

If viremic sera from mice chronically infected with lactic dehydrogenase virus (LDV) were first treated with ether or ultraviolet light to inactivate the infectious virus, neutralizing antibody could be demonstrated. Significant amounts of antibody, however, were not detected until the mice had been infected for about 2(1/2) months and its presence did not result in the elimination of the chronic viremia. Virus isolated from sera containing neutralizing antibody was found to be relatively resistant to neutralization by anti-LDV. Further studies revealed that the resistant virus existed in the form of an infectious virus-antibody complex (sensitized virus). The presence of such a complex was demonstrated by the fact that the virus fraction which persisted after in vivo or in vitro exposure to mouse anti-LDV was readily neutralized by goat anti-mouse sera or goat anti-mouse gamma-globulin, whereas virus that had not been previously exposed to mouse anti-LDV was completely resistant to neutralization by goat anti-mouse sera. These findings suggest that (a) sensitization may play an important role in the resistance and susceptibility of a virus to neutralization by antiviral antibody, and (b) an anti-gamma-globulin may prove useful in neutralizing the resistant fraction and in demonstrating otherwise undetectable antiviral antibody.

PubMed Disclaimer

References

    1. J Immunol. 1956 Mar;76(3):200-8 - PubMed
    1. Ann N Y Acad Sci. 1960 Jan 13;83:515-27 - PubMed
    1. Virology. 1963 Mar;19:261-72 - PubMed
    1. Virology. 1956 Apr;2(2):162-205 - PubMed
    1. Virology. 1965 Aug;26(4):528-37 - PubMed